The University of Colorado Cancer Center has recruited Steven Thorpe, MD, FACS, a renowned orthopedic surgical oncologist and a sarcoma and limb-salvage specialist, to join the Department of Orthopedics at the CU School of Medicine as the new chief of the musculoskeletal oncology program.
Jeanette Waxmonsky, PhD, associate clinical professor in the Colorado School of Public Health and associate clinical professor of family medicine in the University of Colorado School of Medicine, has been named assistant director for community-engaged research for the Office of Community Outreach and Engagement at the CU Cancer Center.
A key yardstick used to evaluate success in cancer treatment shows that for many cancers, a higher percentage of people diagnosed at the University of Colorado Cancer Center have survived five years or more beyond their diagnoses than for the nation as a whole.
As senior associate athletic director for health and performance at the University of Colorado Boulder, Miguel Rueda is used to overseeing the wellness of student-athletes in sports ranging from football and basketball to golf, skiing, and lacrosse.
In all medical research, but particularly in cancer research, clinical trials save lives. They test the great new discoveries that can combat cancer, and the only way we're going to get better at preventing, diagnosing, and treating cancer is to put our best drugs and techniques forward and test them.
In the realm of cancer research, clinical trials can lead to more effective drugs, better treatments, and ways to prevent and detect cancer. They are a key step in the journey from scientific discoveries to helping current and future patients. Clinical trials are a major factor behind a 33% drop in the U.S. cancer death rate and an estimated 3.8 million cancer deaths avoided over the last four decades.
All women need to pay attention to their risk factors for breast cancer and ovarian cancer, but women of Eastern European (Ashkenazi) Jewish ancestry should be especially vigilant, says University of Colorado Cancer Center member Marie Wood, MD, as their risk for having a genetic variant in the BRCA1 or BRCA2 genes is increased, predisposing them to developing hereditary breast and ovarian cancer.
It looks pretty simple: A capsule the size of a jelly bean, attached to a string. And yet, it shows promise as an answer to a vexing question in the fight against esophageal cancer and other diseases of the upper digestive tract: How to spare patients from repeated endoscopies and biopsies.
University of Colorado Cancer Center Associate Director of Clinical Research, Christopher Lieu, MD, is bringing his wealth of expertise and dedication to a new role as the Vice Chair of the National Comprehensive Cancer Network (NCCN).
Gary and Kathy Kortz, partners in marriage for nearly three decades, have also been partners in giving generously of their time and philanthropy for many years to support the University of Colorado Cancer Center and cancer research in general.
Combining targeted therapies known as tyrosine kinase inhibitors (TKIs) can be an effective way to treat a mutation-driven form of lung cancer in cases where tumors develop resistance to treatment and where cancer has spread to other parts of the body, a University of Colorado Cancer Center member reports.
Mark Koebrich's heartburn, a lifelong companion through nearly four decades in television, took a turn for the worse after retirement, prompting him to seek medical advice. His general practitioner referred him to UCHealth University of Colorado Hospital, where he met Sachin Wani, MD, the Endowed Chair of the Katy O. and Paul M. Esophageal and Gastric Center of Excellence. Koebrich was diagnosed with Barrett's esophagus with low-grade dysplasia, a precancerous condition, and was enrolled in the SURVENT trial, a groundbreaking study offering cutting-edge treatment options.
Matt Lubick had finished marathons before, but none was so personally meaningful as the 26-mile distance he covered in one day while being treated for leukemia at UCHealth University of Colorado Hospital. Lubick walked dozens of laps around the facility, wheeling his IV pole up and down the corridors as day slowly turned to night outside the tall glass windows.
The University of Colorado Cancer Center is distributing free colorectal cancer screening kits that can be used at home, targeting uninsured people across Colorado with lower rates of screening for a cancer that is the No. 2 cause of cancer deaths.
The results of a multisite clinical trial overseen by University of Colorado Cancer Center member Bradley Corr, MD, could offer new hope to patients with metastatic and recurrent uterine cancer, also known as endometrial cancer.
Bringing new attention to breast cancer in younger women and the importance of risk assessment, actress Olivia Munn, 43, announced Wednesday that she had been diagnosed with the disease last year. Munn said she has undergone four surgeries in the past 10 months, including a double mastectomy.
Gabriel Charpentier began experiencing symptoms of stomach discomfort and fatigue at 34. Despite negative tests, he advocated for a colon cancer scan, leading to his diagnosis and participation in an immunotherapy clinical trial. His oncologist, University of Colorado Cancer Center member, Alexis Leal, MD, highlights the importance of clinical trials and the remarkable response Gabriel had to immunotherapy.
A prestigious invitation to chair an educational program session at the annual meeting of the American Society of Hematology (ASH) in December 2023 offered University of Colorado Cancer Center member Manali Kamdar, MD, an opportunity to update the profession about two increasingly common treatments for relapsed lymphomas.
A project to improve the effectiveness of endoscopic surgery, led by University of Colorado Cancer Center member Steven Edmundowicz, MD, is one of nine research endeavors to be awarded major funding from the Anschutz Acceleration Initiative (AAI).
After eight years of work by a pair of University of Colorado Cancer Center leaders on a new way to attack various cancers, the next stage in their quest to bring their therapy to patients is one of nine research endeavors receiving funding from the Anschutz Acceleration Initiative (AAI).
Country music star Toby Keith died February 5, 2024 at age 62, according to an announcement on his official website, following his battle with stomach cancer, also known as gastric cancer. The following blog post on his cancer was published June 14, 2022, shortly after he publicly disclosed his diagnosis.
University of Colorado Cancer Center member Maryam Asgari, MD, MPH, is one of nine CU School of Medicine faculty members to be awarded an Anschutz Acceleration Initiative grant. The winning projects, announced in January, were chosen for their promise to deliver life-changing advancements in medicine within the next three to five years.
The American Cancer Society (ACS) says it expects more than 2 million new U.S. cancer cases this year, the highest one-year total ever, with rising rates for six of the 10 most common cancers. In Colorado, 29,430 new cancers are projected in 2024.
A vaccine that prevents all cancer may still be decades away from becoming a reality, but for cervical cancer and several other types of cancer, a vaccine already exists that drastically reduces the risk of getting the disease.
On a mission to put an end to colorectal cancer, the Colorectal Cancer Alliance (CCA) recently launched Project Cure CRC, an initiative aimed at funding tens of millions of dollars in expedited, novel colorectal cancer research over the next two years.
University of Colorado Cancer Center member Sana Karam, MD, PhD, has received a translational research grant from the V Foundation for Cancer Research, co-founded by ESPN and legendary basketball coach Jim Valvano, to study a new therapeutic that may help pancreatic cancer patients overcome resistance to radiation therapy.
As word of the effectiveness of chimeric antigen receptor, or CAR T-cell therapy, for blood cancer continues to spread, excitement is growing about the new treatment and the possibilities it offers for patients with blood cancers and other types of cancer.
Chemotherapy is a useful treatment to try to get systemic control in pancreatic cancer. Currently, however, chemotherapy is mostly administered in patients whose tumors are more difficult to remove surgically because of where they are in the anatomy.
Yoga, massage, and bright white light therapy are among the effective ways to manage cancer-related fatigue, according to new patient guidelines from the National Comprehensive Cancer Network (NCCN).
Ovarian cancer is a growing area of research at the University of Colorado Cancer Center. A newly formed Ovarian Cancer Innovations Group, envisioned by Saketh Guntupalli, MD, and led by Kian Behbakht, MD, MBA, is taking a multipronged approach to studying the disease.
With an eye on outcomes that range from better patient care and improved early detection to equity in research and increased use of new technologies like big data, the National Cancer Institute (NCI) recently rolled out a National Cancer Plan.
Colorado is a winter playground, whether your passion is skiing, snowboarding, snowshoeing, or just throwing snowballs. But the bright sun that helps make winter sports in the Rockies so delightful also poses a threat to your skin.
This November, Stomach Cancer Awareness Month allows us the opportunity to learn more about gastric oncology and dispel anxieties around the disease. While stomach cancer, also known as gastric cancer, accounts for a little over 1% of all new cancer cases per year, outcomes can be improved with prevention and earlier detection.
Jamie L. Studts, PhD, co-leader of the Cancer Prevention and Control Program at the University of Colorado Cancer Center, is part of a research team that recently received a $250,000 award to build a coalition of lung cancer survivors and caregivers. Studts and colleagues at Memorial Sloan Kettering Cancer Center and GO2 for Lung Cancer will work with the coalition to develop research priorities focused on improving health outcomes.
6022c96aab